Edges in Network
| Network | GSE12093_egf1520 - GSE12093 - SiGN-BN HC+Bootstrap |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | SLC25A32 |
| Upstream (Parents) |
|---|
| (<<) ATP2A2 → SLC25A32 |
| (<<) ITGAV → SLC25A32 |
| (<<) KHDRBS1 → SLC25A32 |
| (<<) MAPK1 → SLC25A32 |
| (<<) MKNK2 → SLC25A32 |
| (<<) PTK2 → SLC25A32 |
| (<<) RNF11 → SLC25A32 |
| (<<) RNF111 → SLC25A32 |
| (<<) RNF138 → SLC25A32 |
| (<<) RPS6KA1 → SLC25A32 |
| (<<) SET → SLC25A32 |
| (<<) TCOF1 → SLC25A32 |
| (<<) TOP2B → SLC25A32 |
| (<<) UBQLN2 → SLC25A32 |
| Downstream (Children) |
|---|
| SLC25A32 → CXCR7 (>>) |
| SLC25A32 → DYNLL1 (>>) |
| SLC25A32 → E2F5 (>>) |
| SLC25A32 → FZD6 (>>) |
| SLC25A32 → GNG12 (>>) |
| SLC25A32 → HS3ST1 (>>) |
| SLC25A32 → IMPA1 (>>) |
| SLC25A32 → ITPR1 (>>) |
| SLC25A32 → KLF10 (>>) |
| SLC25A32 → MAP3K11 (>>) |
| SLC25A32 → MTHFD2 (>>) |
| SLC25A32 → NDRG1 (>>) |
| SLC25A32 → NFKBIA (>>) |
| SLC25A32 → NOC3L (>>) |
| SLC25A32 → PABPC3 (>>) |
| SLC25A32 → PNO1 (>>) |
| SLC25A32 → SEH1L (>>) |
| SLC25A32 → SLC25A37 (>>) |
| SLC25A32 → SLC7A5 (>>) |
| SLC25A32 → SLMO2 (>>) |
| SLC25A32 → TCEB1 (>>) |
| SLC25A32 → WNT7B (>>) |
